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Synthesis and Avidin Binding of Ruthenium Complexes
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Bianka Siewert,[a][‡] Michiel Langerman,[a] Andrea Pannwitz,[a] and Sylvestre Bonnet*[a]
Abstract: In this work the synthesis, photochemistry, and
streptavidin interaction of new [Ru(tpy)(bpy)(SRR′)](PF6)2 com-
plexes where the R′ group contains a free biotin ligand, are
described. Two different ligands SRR′ were investigated: An
asymmetric ligand 1 where the Ru-bound thioether is a N-
acetylmethionine moiety linked to the free biotin fragment via
a triethylene glycol spacer and a symmetrical ligand 2 contain-
ing two identical biotin moieties. The coordination of these two
ligands to the precursor [Ru(tpy)(bpy)Cl]Cl was studied in water
at 80 °C. In such conditions the coordination of the asymmetric
ligand 1 occurred under thermodynamic control. After the reac-
tion, a mononuclear and a binuclear complex were isolated. In
the mononuclear complex, the ratio of methionine- {[6](PF6)2}
Introduction
One of the strongest known non-covalent interactions in nature
is the one between (strept)avidin and biotin (kd = 10–13 to
10 –15 L mol–1).[1] Once the avidin-biotin complex (ABC) is
formed only extremely harsh conditions (6 M guanidine-HCl,
pH = 1.5) will lead to disassembly.[2] This phenomenon, discov-
ered 48 years ago, led to the emergence of the ABC field in
biotechnology.[1,3] (Strept)avidin systems are utilized for biocon-
jugates, for theranostic purposes, but also as tumor-targeting
strategy,[4] for which the high affinity of biotin for avidin is criti-
cal.[3] Recently, e.g. an almost ten-fold increase of cellular up-
take of microspheres was reached by employing the ABC tech-
nique.[5] However, for drug-delivery strong binding also repre-
sent the major drawback, as it is difficult to obtain efficient
release of the targeting moiety.[6] Typically, targeting the cancer
cells works well, but less cytotoxicity is observed, because the
drug is not efficiently released from its targeting group and
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vs. biotin-bound {[7](PF6)2} regioisomer was 5.3 and the free
biotin fragment of [6](PF6)2 allowed to purify it from its isomer
[7](PF6)2 at small scales using avidin affinity chromatography.
Coordination of the symmetrical ligand 2 afforded [Ru(tpy)-
(bpy)(2)](PF6)2 {[8](PF6)2} in synthetically useful scales (100 mg),
good yield (82 %), and without traces of the binuclear impurity.
In this complex, one of the biotin remains free whereas the
second one is coordinated to ruthenium. Photochemical release
of ligand 2 from [8](PF6)2 occurred upon blue light irradiation
(465 nm) with a photosubstitution quantum yield of 0.011 that
was independent of the binding of streptavidin to the free bio-
tin ligand.
thus trapped in the endosomes for example.[6] To solve this
issue, strategies with pre-determined “break junctions” have
been developed. For example, the targeting fragment can be
bound via linkers that are sensitive to intracellular triggers, such
as pH, proteases, or glutathione concentration.[6] These strate-
gies, however, lack temporal and spatial control. Light activation
would solve this issue by allowing to release the targeting moi-
ety by an external trigger, i.e. photons.[7] We reported earlier on
a method to cleave methionine- and biotin-based ligands from
a ruthenium(II) polypyridyl complex using visible light.[8] Fol-
lowing the steps of Lo et al.,[9] Ward et al,[10] and others,[11] who
showed that biotin-tagged metal compounds could keep the
biotin affinity for (strept)avidin, we embarked on investigating
synthetically useful methods to functionalize photosubstitu-
tionally active ruthenium polypyridyl complexes such as
[Ru(tpy)(bpy)(Cl)]Cl with a free biotin fragment that can be re-
moved by visible light, for future use in photochemother-
apy.[12,13]
Results and Discussion
Ligand Design and Synthesis
Thioether groups such as those found in N-acetylmethionine or
biotin are excellent ligands for ruthenium(II) polypyridyl com-
plexes that can be cleaved by visible light irradiation.[8c] The
dissymmetric ligand 1 that contains both sulfur donors sepa-
rated by a short ethylene glycol spacer was hence designed
first (Scheme 1). Based on the higher thermal stability of
N-acetylmethionine ruthenium complexes compared to biotin
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Scheme 1. Overview of the synthetic routes used to obtain bis-thioether ligands 1 and 2.
adducts,[8c] we hypothesized that coordination of the sterically
less hindered methionine fragment of 1 may be preferred over
that of biotin. In the symmetrical bis-biotinylated ligand 2, on
the contrary, one biotin should coordinate to ruthenium, while
the second, identical fragment should remain free to interact
with streptavidin.
The first step in the synthesis of 1 (Scheme 1) involved the
activation of biotin with disuccinimidyl carbonate to obtain the
N-hydroxysuccinimidyl ester of biotin, biotin-NHS (3).[14] In a
second step, compound 3 was treated with 5 equiv. of the
linker 2,2′-(ethylenedioxy)bis(ethylamine) in DMF at room temp.
which afforded the mono-biotin (4) ligand. The final reaction of
4 with N-acetyl-L-methionine (HAmet) afforded 1 as colorless,
viscous oil in 72 % yield. Full characterization of ligand 1 was
performed by NMR, ESI MS, and HRMS measurements (see Sup-
porting Information). Ligand 2 was easily obtained from the
bisamine spacer used for 1 and two equivalents of NHS-biotin
3 (see Scheme 1 and Experimental Part).
Coordination of 1 and 2 to Ruthenium
For the synthesis of [Ru(tpy)(bpy)(1)](Cl)2 ([6]Cl2, Scheme 2),
[Ru(tpy)(bpy)Cl]Cl was treated with 1 in water at 80 °C over
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three days. Under these conditions, the chloride precursor hy-
drolyses quickly[8c] to the aqua complex [Ru(tpy)(bpy)(OH2)]2+,
which reacts with one or the other thioether moiety. After
workup and column chromatography on silica, two different
fractions were obtained. The 1H NMR (Figure S1) of the more
polar fraction (Rf = 0.1, acetone/H2O/1 M HCl [16:4:1]) showed
two signals with the same integral between δ = 9.50–
10.00 ppm, indicating two downfield-shifted A6 protons on the
bipyridine ligand instead of the expected unique doublet (see
Scheme 2).[8c] Furthermore, the sum of integrals of the aromatic
part was twice as high as that of the aliphatic part. Additionally,
all methyl and methylene groups in close proximity to the
sulfur-atoms showed a significant downfield shift. This charac-
teristic observation emerges from the shielding cone of the
polypyridyl ligands when a monodentate ligand is coordinated
to the ruthenium polypyridyl moiety.[15] Taken together, NMR
analysis indicated that this fraction contained a binuclear ruth-
enium complex [5]Cl4 (Scheme 2). This hypothesis was con-
firmed by mass spectrometry; a peak at m/z = 528.1 was found,
which fits the calculated m/z value for [{Ru(tpy)(bpy)}2(1) + H2O
+ Cl]3+ (528.1). For the less polar fraction (Rf = 0.3, acetone/
H2O/1 M HCl [16:4:1]), mass analysis showed the expected peak
at m/z = 519.2 for the mononuclear ruthenium complex
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Scheme 2. Coordination of 1 equiv. of 1 with [Ru(tpy)(bpy)Cl]Cl in water at 80 °C over three days yielded a mixture of a binuclear complex [5]Cl4 and two
mononuclear isomer complexes [6]Cl2 and [7]Cl2.
[Ru(tpy)(bpy)(1)]2+ (calcd. m/z = 519.12). According to 1H-NMR
spectroscopy, the integral ratio between the characteristic sig-
nals of the aromatic part and that of the aliphatic part was
close to one. Further analysis of the 1H NMR revealed significant
up-field shifts for the methyl signal of the methionine fragment
(e.g. Δδ = –0.74 ppm for M1), which proved the formation of
the desired mononuclear ruthenium complex [6]Cl2 coordi-
nated via the sulfur of the N-Acetylmethionine methionine as
major isomer (Scheme 2). However, next to the characteristic
A6 signal at δ = 9.75 ppm for [6]2+, a smaller A6 doublet at δ =
9.85 ppm (3J = 5.5 Hz) was observed (Figure S2), suggesting a
mixture of two isomers. The integral ratio between these two
Figure 1. (A) Evolution of the 1H NMR spectra (300 MHz, D2O) during the coordination of ligand 1 to [Ru(tpy)(bpy)(OH2)](PF6)2 in D2O. (B) The [6]2+:[7]2+ ratio
obtained from integration of the A6 proton peaks in the 10.0–9.4 ppm range, plotted vs. reaction time. Conditions: [Ru]0 = 4.2 mM, [1] = 42 mM, T = 353 K,
in the dark. Blue diamond = [Ru(tpy)(bpy)(OH2)]2+ (δ = 9.54 ppm), green square = [6]2+(δ = 9.76 ppm), orange circle = [7]2+(δ = 9.86 ppm).
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A6 peaks showed that [6]2+ was 83 % pure. The second, minor
isomer is the biotin-coordinated complex [7]2+, as shown by
the identical mass spectrum but shifted chemical resonances of
the biotin signals. Silica column chromatography enriched [6]2+
to some extent, however, a pure compound (> 99 % purity)
could not be obtained under these conditions.
In a next step, the synthetic conditions were varied to evalu-
ate whether [6]2+ could be obtained regioselectively. By increas-
ing the ligand-to-Ru ratio, we successfully suppressed the for-
mation of the binuclear complex [5]4+. Changing the reaction
times and using higher reaction temperatures showed an en-
richment of the desired isomer [6]2+ and thus suggested that
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Scheme 3. Coordination of 5 equiv. of 2 with [Ru(tpy)(bpy)Cl]Cl in water at 80 °C yielded [8](PF6)2.
the selectivity of the reaction towards [6]2+ was not driven by
kinetics, but the result of thermodynamic control. The equilibra-
tion process between 1, [Ru(tpy)(bpy)(OH2)]2+, [6]2+, and [7]2+
was hence followed in time by 1H NMR at 80 °C, as the reaction
between the aqua complex and the sulfur donor is not ob-
served below 50 °C. After the first 45 minutes [6]2+ and [7]2+
had formed in a ratio of 51:49, which showed that there was
no measurable kinetic preference for one or the other isomer.
The amount of [6]2+ in the reaction mixture quickly increased
thereafter, to finally reach a plateau characterized by a
[6]2+:[7]2+ ratio of 84:16 after 24 h (Figure 1). From these data,
we concluded that the regioselectivity of the coordination to
ruthenium of the methionine fragment in 1 vs. that of biotin, is
due to the higher thermodynamic stability of the methionine-
coordinate isomer [6]2+, compared to [7]2+, rather than to a
slower reaction of biotin. According to our data, the binding
constant of [6]2+ is ca. 5 times higher than that of [7]2+, which
is too low to drive the formation of analytically pure complex
[6]2+. However, it was possible to purify [6]2+ from [7]2+ in small
scales using avidin chromatography (see below).
Analytically pure samples of a biotin-functionalized ruth-
enium complex were obtained in preparative scale using the
symmetrical ligand 2. Thermal reaction of an excess of 2 to
[Ru(tpy)(bpy)(OH2)](PF6)2 in water at 80 °C, followed by silica gel
chromatography, afforded the mononuclear adduct [8](PF6)2
(Scheme 3) in ca. 100 mg scale and 81 % yield. Coordination of
only one of the two biotin moieties to ruthenium and structural
information about the stereochemical orientation of the biotin
ligand in [8]2+ was obtained by a combination of 2D NMR stud-
ies (NOESY, COSY, HMBC, HSQC), ESI MS, and elemental analysis.
Based on these results (see Supporting Information), the 1,8-
diamino-3,6-dioxaoctane linker has no significant effect on the
coordination mode of biotin to ruthenium, compared to the
known crystal structure of the adduct [Ru(tpy)(bpy)(biotin
methyl ester)]2+.[8c]
Photochemical Investigation
Ruthenium polypyridyl complexes are known for their rich pho-
tochemistry.[16] Excitation into the metal-to-ligand charge trans-
fer (MLCT) absorption band leads to either emission, singlet
oxygen production, or ligand photosubstitution. The concrete
outcome depends on the ligand field splitting of the com-
plex.[16] For complexes of the [Ru(tpy)(bpy)(L)]2+ family, emis-
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sion and singlet oxygen production are generally negligible as
dissociative, metal-centered triplet excited states (3MC) lie ener-
getically close to the photochemically generated 3MLCT
states.[17] The photochemistry of compound [8](PF6)2 was stud-
ied under blue light irradiation (λ = 465 nm, Δλ1/2 = 25 nm,
photon flux 1.29 × 10–8 mol s–1) in PBS (pH = 7.03, I = 50 mM,
[Ru]0 = 7.6 × 10–5 M) for 4 h at 298 K using a setup described
earlier.[8c] An isosbestic point was observed at 445 nm, indicat-
ing that a single photochemical reaction occurred; the photo-
stationary state was reached after 80 minutes (Figure S7). Mass
spectrometry measurements after irradiation confirmed that
photosubstitution of ligand 2 by water had occurred, as the
initial peak at m/z = 545.4 for [8]2+ was replaced by a peak at
m/z = 508.1 characteristic for [Ru(tpy)(bpy)(OH)]+ (calcd. m/z =
508.1). The photosubstitution rate constant kΦ = 7.1 × 10–4 s–1
was obtained from the slope of a plot of ln([RuS]/[Ru]0) vs. the
irradiation time, where [RuS] represents the concentration of
[8]2+ at time t, and [Ru]0 the total ruthenium concentration. The
corresponding photosubstitution quantum yield was derived
from the slope of a plot of the number of mol of thioether
complex, nRuS, vs. the number of mol of photons, Q, absorbed
since t = 0, according to the methods described in the experi-
mental part (see also Figure S6). A photosubstitution quantum
yield of 0.011 was found, which is higher, but about the same
order of magnitude as the one found for the substitution of
[Ru(typ)(bpy)(SChol)]2+ by water (φ = 0.0078).[18]
Binding of [8]2+ to Streptavidin and Photosubstitution
In order to check the suitability of [8]2+ for the ABC technology,
a HABA [2-(4-hydroxyphenylazo)benzoic acid] displacement ti-
tration was applied to test the binding behavior of [8]2+ to
streptavidin. HABA exhibits a characteristic absorption band
with λmax at 506 nm when incorporated within streptavidin.
Upon addition of four equivalents of biotin per streptavidin
tetramer, the HABA is displaced leading to disappearance of the
absorption band at 506 nm.[19] Upon addition of more than
four equivalents of biotin, the absorbance at 506 nm is con-
stant. This behavior was also observed for [8]2+ and indicates
an equally strong binding as biotin (Figure 2A). A slight increase
in absorbance upon addition of more than four equivalents is
due to the absorbance of [8]2+ itself. Irradiation of [8]2+ in ab-
sence and in presence of one equivalent tetrameric streptavidin
in NaH2PO4 buffer (3.00 mL, 20 mM, pH 7.0) with blue light (λ =
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465 nm, Δλ1/2 = 25 nm) yielded the same spectroscopic
changes as described in the previous section (Figure 2B). This
observation meant that [8]2+ is furthermore a promising candi-
date for ABC-based strategies, as the linker in 2 is long enough,
so that the free biotin in complex [8]2+ still reaches the avidin
binding pocket. In addition, the observed behavior of [8]2+ in
the presence of streptavidin (Figure 2A) shows that the complex
is kinetically stable under such conditions.
Figure 2. (A) Displacement titration of HABA within streptavidin by [8]2+
and biotin in NaH2PO4 buffer (2.7 mL, 20 mM, pH 7.0). (B) Evolution of the
absorbance at 475 nm upon irradiation at λ = 465 nm (Δλ1/2 = 25 nm) of
6.0 × 10–5 M [8]2+ in absence and in presence of one equivalent tetrameric
streptavidin in NaH2PO4 buffer (3.00 mL, 20 mM, pH 7.0).
Application of the Selective Streptavidin Binding
The observation that the free biotin in [8]2+ interacted strongly
with streptavidin suggested avidin-based column chromatogra-
phy as a potential method to separate the isomeric mixture of
[6]2+ and [7]2+ mentioned above. An avidin column was hence
incubated for 24 h with a mixture of [6]2+/[7]2+ in PBS. In a
second step, the unbound complex mixture was washed from
the column using buffer (PBS). Then, a biotin-loaded PBS buffer
was used to displace the non-coordinated, avidin-bound biotin
moiety in [6]2+, with native biotin. This procedure yielded a
mixture of [6]2+ and native biotin without traces of [7]2+, as
shown by the unique A6 proton in the aromatic region of the
1H NMR spectrum of the purified sample (9.6–10.0 ppm, Fig-
ure 3). The low loading capacity and high price of commercially
available avidin-based purifications columns, however, was not
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suitable for a large scale separation of [6]2+, but it confirmed
that the dangling biotin moiety in [6]2+ can still interact selec-
tively with streptavidin.
Figure 3. Comparison of the 1H NMR spectra (D2O, 300 MHz, zoom of A6
proton peaks) of the isomeric mixture [6]2+ and [7]2+ (top) and the isolated
complex [6]2+ (bottom), before and after avidin affinity column chromatogra-
phy, respectively.
Conclusions
In summary, the two different biotin-containing thioether li-
gands 1 and 2, when coordinated to [Ru(tpy)(bpy)(OH2)]2+ in
water, led to different results. The coordination of ligand 1 to
[Ru(tpy)(bpy)Cl]Cl provided one of the rare regioselectivity
study of the binding of thioethers to ruthenium(II). It showed
that in the conditions of the experiment coordination is under
thermodynamic control and that although biotin is more hin-
dering than N-acetylmethionine, the thermodynamic prefer-
ence for [6]2+ vs. [7]2+ was not strong enough to lead to the
regioselective preparation of [6]2+. Purification of [6]2+ from its
regioisomer [7]2+ eventually succeeded in low scale via avidin-
affinity chromatography, proving that in [6]2+ the free biotin
moiety allows for establishing strong interactions with
(strept)avidin.
The symmetrical bis-biotin ligand 2 offered a more straight-
forward and synthetically useful route towards the preparation
of a ruthenium complex with a light-cleavable, free biotin
group. Complex [8](PF6)2 was obtained in ca. 100 mg scale with
good yields (82 %). Meanwhile, photochemical studies with
[8]2+ showed that, whether or not the dangling, non-coordi-
nated biotin moiety was bound to streptavidin, efficient photo-
substitution of the coordinated biotin ligand occurred, thus
providing a proof-of-concept that light-cleavable free biotin
moieties can be installed on photoactivated chemotherapeutic
complexes to prepare streptavidin-mediated targeted PACT
systems. The synthetic strategy presented in this work would
circumvent current problems of (strept)avidin-biotin based can-
cer-targeting methods, where the biologically active drug re-
mains covalently bound to the biotin targeting group.
Experimental Section
Materials and Methods: Biotin was obtained from TCI Chemicals,
N,N-diisopropylethylamine (DIPEA) was obtained from Acros Organ-
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ics. Disuccinimidyl carbonate, 1,8-diamino-3,6-dioxaoctane, N,N′-
diisopropylcarbodiimide (DIC), 4-dimethylaminopyridine (DMAP),
Et3N and HABA [2-(4-hydroxyphenylazo)benzoic acid] were ob-
tained from Sigma Aldrich. DSPE-PEG-2 K-Biotin [385437-57-0] was
obtained from Nanocs. [Ru(tpy)(bpy)(Cl)]Cl and [Ru(tpy)(bpy)(OH2)]-
(PF6)2 were synthesized following literature procedures[20] as well
as wild type streptavidin.[21] DMF was obtained from Alfa Aesar and
dried with molecular sieves (3 Å). DCM was obtained from Alfa
Aesar and dried using a PureSolve 400 solvent dispenser. Silica gel
(60 Å, 230–400 mesh particle size, Ca ≈ 0.1 %) was used for column
chromatography. Size exclusion chromatography was done over Se-
phadex LH-20 prepared in MeOH. Avidin affinity column chroma-
tography was done with a 2 mL Pierce Monomeric Avidin Agarose
Kit from Thermo Scientific. 1H NMR and 13C NMR spectra were re-
corded with a Bruker DPX 300 spectrometer or a Bruker DMX 400
spectrometer. Chemical shifts are indicated in ppm relative to TMS.
Numbering of the compounds and NMR spectra can be found in
the Supporting Information. Mass spectra were recorded on a Ther-
moQuest Finnigan AQA spectrometer. UV/Vis spectra were obtained
on a Varian Cary 50 UV/Visible spectrometer. The irradiation setup
for UV/Vis experiments consisted of custom made LEDs directly
placed on top of a 1 cm quartz cuvette, as described by Bahreman
et al.[22]
Biotin-NHS (3): Biotin (1.00 g, 4.10 mmol), disuccinimidyl carbonate
(1.37 g, 5.33 mmol), and Et3N (2.30 mL, 16.4 mmol) were added to
dry DMF (14 mL). The resulting suspension was stirred at room
temperature under argon for 16 h. The solvent was removed by
vacuum distillation at 323 K. The resulting solid was triturated in
diethyl ether and ethyl acetate and subsequently filtered and
washed with diethyl ether over a glass filter. The white powder was
dried under air. Yield: 1.26 g (3.70 mmol, 90 %). Rf = 0.68 (SiO2,
BuOH/H2O/AcOH [3:1:1]). 1H NMR (300 MHz, [D]Chloroform): δ =
(ppm): 4.60–4.49 (m, 1 H), 4.36 (dd, J = 7.9, 4.5 Hz, 1 H), 3.17 (td,
J = 7.2, 4.5 Hz, 1 H), 2.94 (dd, J = 12.8, 5.0 Hz, 1 H), 2.89–2.81 (m, 4
H), 2.75 (d, 2 H), 2.65 (q, J = 7.0 Hz, 2 H), 1.93–1.65 (m, 6 H), 1.57
(q, J = 7.6 Hz, 2 H). 1H NMR spectroscopic data is in agreement with
known literature.[23]
N-Biotinyl-8-amino-3,6-dioxaoctane-1-amonium Acetate (4):
Compound 3 (560 mg, 1.64 mmol) was dissolved in DMF (6 mL).
The solution was added dropwise to a solution of 1,8-diamino-3,6-
dioxaoctane (1.20 mL, 8.20 mmol) and Et3N (1.14 mL, 8.20 mmol)
in DCM (24 mL). The resulting solution was stirred at room tempera-
ture for 5 h, after which the solvents were removed in vacuo to
give an oil. The crude product was purified twice by silica column
chromatography using butanol/H2O/acetic acid (3:1:1) as the eluent.
Excess of acetic acid was removed by co-evaporation with toluene.
Yield: 547 mg (1.26 mmol, 77 %). Rf = 0.33 (SiO2, butanol/H2O/acetic
acid [3:1:1]). 1H NMR (400 MHz, [D4]methanol): δ = (ppm): 4.50 (dd,
J = 7.9, 4.8 Hz, 1 H, H2), 4.31 (dd, J = 7.8, 4.4 Hz, 1 H, H3), 3.70 (t,
J = 4.9 Hz, 2 H, H13), 3.66 (s, 4 H, H11 + H12), 3.56 (t, J = 5.6 Hz, 2
H, H10), 3.37 (t, J = 5.6 Hz, 2 H, H9), 3.21 (ddd, J = 8.9, 5.8, 4.4 Hz,
1 H, H4), 3.11 (t, J = 4.7 Hz, 3 H, H14), 2.93 (dd, J = 12.7, J = 4.9 Hz,
1 H, H1B), 2.71 (d, J = 12.7 Hz, 1 H, H1A), 2.23 (t, J = 7.3 Hz, 2 H,
H8), 1.91 (s, 3 H, CH3), 1.79–1.54 (m, 4 H, H5 + H7), 1.44 (p, J =
7.6 Hz, 2 H, H6). 13C NMR (75 MHz, [D4]methanol): δ =(ppm): 178.9
(C=O), 176.2 (Cb), 166.1 (Ca), 71.4 + 71.3 (C11 + C12), 70.7 (C10),
68.0 (C13), 63.4 (C3), 61.6 (C2), 57.0 (C4), 41.0 (C1), 40.6 (C14), 40.2
(C9), 36.7 (C8), 29.7 (C6), 29.5 (C5), 26.9 (C7), 23.1 (CH3). ESI MS: m/z
(calc): 375.1 (375.2, [M – AcO]+).
N′′-(Acetyl-L-methionine)-N′-biotinyl-3,6-dioxaoctane-1,8-di-
amine (1): N-acetyl-L-methionine (512 mg, 2.68 mmol) and N,N′-
diisopropylcarbodiimide (DIC) (411 mg, 3.26 mmol) were dissolved
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in DMF (15 mL) and the resulting turbid solution was added drop-
wise to a suspension of compound 4 (1.12 mg, 2.57 mmol) in DMF
(20 mL). DIPEA (0.885 mL, 5.35 mmol) and DMAP (37.1 mg,
0.30 mmol) were subsequently added. The resulting mixture was
stirred under argon at room temperature for 20 h, after which DMF
was removed by vacuum distillation at 323 K. The crude product
was dissolved in H2O and the precipitated DIPEA was filtered off
and washed with H2O. Water was removed by rotary evaporation
and the crude oil was purified by silica column chromatography
using DCM/MeOH (8:2) as eluent. Yield: 1.01 g (1.84 mmol, 72 %).
Rf = 0.7 (SiO2, DCM/MeOH [8:2]). 1H NMR (300 MHz, [D4]methanol):
δ = (ppm): 8.24 (d, J = 7.6 Hz, 1 H, NH), 8.09 (t, J = 5.2 Hz, 1 H, NH),
8.01 (t, J = 5.5 Hz, 1 H, NH), 6.57 (s, 1 H, NH), 6.45 (s, 1 H, NH), 4.50
(dd, J = 7.8, 4.3 Hz, 1 H, H2), 4.44 (dd, J = 8.6, 5.5 Hz, 1 H, M4), 4.32
(dd, J = 7.9, 4.4 Hz, 1 H, H3), 3.62 (s, 4 H, H11 + H12), 3.55 (t, J =
5.4 Hz, 4 H, H10 + H13), 3.43–3.33 (m, 4 H, H9 + H14), 3.21 (ddd,
J = 8.8, 5.8, 4.4 Hz, 1 H, H4), 2.93 (dd, J = 12.8, J = 4.9 Hz, 1 H, H1B),
2.71 (d, J = 12.7 Hz, 1 H, H1A), 2.63–2.42 (m, 2 H, M2), 2.23 (t, J =
7.3 Hz, 2 H, H8), 2.09 (s, 3 H, M1), 2.00 (s, 3 H, M5), 2.12–1.81 (m, 2
H, M3), 1.84–1.50 (m, 4 H, H5 + H7), 1.44 (p, J = 7.2 Hz, 2 H, H6).
13C NMR (75 MHz, [D4]methanol): δ =(ppm): 176.1 (Cb), 174.0 (Cc),
173.3 (Cd), 166.0 (Ca), 71.3 (C11 + C12), 70.6 + 70.4 (C10 + C13),
63.3 (C3), 61.6 (C2), 57.0 (C4), 54.0 (M4), 41.1 (C1), 40.3 (C9), 40.3
(C14), 36.7 (C8), 32.8 (M3), 31.1 (M2), 29.8 (C6), 29.5 (C5), 26.8 (C7),
22.6 (M5), 15.30 (M1). ESI MS: m/z (calc): 570.3 (570.2 [M + Na]+).
HRMS: m/z (calc): 548.25717 (548.25710 [M + H]+).
Bis(N-biotinyl)-3,6-dioxaoctane-1,8-diamine (2): A solution of
1,8-diamino-3,6-dioxaoctane (110 mg, 0.74 mmol) and Et3N
(152 mg, 1.50 mmol) in dry DMF (1.0 mL) was added to a solution of
compound 3 (500 mg, 1.46 mmol) in dry DMF (15 mL). The resulting
solution was stirred under argon for 26 h at room temperature, after
which the DMF was removed by vacuum distillation at 323 K. The
crude was purified twice by silica column chromatography, using
BuOH/H2O/AcOH (3:1:1) and DCM/MeOH (78:22) as eluents, respec-
tively. Yield: 308 mg (0.51 mmol, 69 %). Rf = 0.38 (SiO2, BuOH/H2O/
AcOH [3:1:1]). 1H NMR (300 MHz, [D4]methanol): δ = (ppm): 4.49
(dd, J = 7.8, 4.8 Hz, 2 H, H2), 4.31 (dd, J = 7.8, 4.4 Hz, 2 H, H3), 3.62
(s, 4 H, H11), 3.55 (t, J = 5.5 Hz, 4 H, H10), 3.37 (t, J = 5.5 Hz, 4 H,
H9), 3.21 (ddd, J = 8.7, 5.6, 4.5 Hz, 2 H, H4), 2.93 (dd, J = 12.8, J =
4.9 Hz, 2 H, H1B), 2.71 (d, J = 12.7 Hz, 2 H, H1A), 2.23 (t, J = 7.3 Hz,
4 H, H8), 1.81–1.55 (m, 8 H, H5 + H7), 1.44 (p, J = 7.2 Hz, 4 H, H6).
13C NMR (75 MHz, [D4]methanol): δ = (ppm): 176.2 (Cb), 71.3 (C11),
70.6 (C10), 63.4 (C3), 61.6 (C2), 57.0 (C4), 41.1 (C1), 40.3 (C9), 36.8
(C8), 29.8 (C6), 29.5 (C5), 26.7 (C7). ESI MS: m/z (calc): 623.4 (623.3
[M + Na]+), 320.2 (320.1 [M + H + K]2+). HRMS: m/z (calc): 601.28364
(601.28365 [M + H]+).
[{Ru(tpy)(bpy)}2(1)]Cl4 and [Ru(tpy)(bpy)(1)]Cl2 (Compounds
[5]Cl2 and [6]Cl2): A solution of ligand 1 (292 mg, 0.533 mmol) in
H2O (15 mL) was deoxygenated with argon and [Ru(tpy)(bpy)Cl]Cl
(299 mg, 0.533 mmol) was added. The resulting solution was stirred
and heated to 353 K over 72 h in the dark under argon. Solvent
was removed by rotary evaporation at 303 K and the crude product
was purified by silica column chromatography using acetone/H2O/
1 M HCl (16:4:1) as the eluent. Two orange fractions (Rf = 0.3 and
Rf = 0.1, acetone/H2O/1 M HCl [16:4:1]) were collected. After removal
of the solvent of the first fraction (Rf = 0.30, acetone/H2O/1 M HCl
[16:4:1]) by rotary evaporation at 303 K, the isomeric mixture [6]Cl2/
[7]Cl2 (83:17) was obtained as an orange powder. Yield: 488 mg
(0.440 mmol, 83 %). The binuclear complex [5]Cl4 was obtained as
a second fraction (Rf = 0.10, SiO2, acetone/H2O/1 M HCl [16:4:1]).
The solvent was removed by rotary evaporation and [5]Cl4 was ob-
tained as an orange powder. Yield: 81 mg (0.048 mmol, 9 %).
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Characterization of [6]Cl2 (Contaminated with [7]Cl2 – See Sup-
porting Information): Rf = 0.30 (SiO2, acetone/H2O/1 M HCl
[16:4:1]). 1H NMR (300 MHz, D2O): δ = (ppm): 9.75 (d, J = 5.5 Hz, 1
H, A6), 8.70–8.63 (m, 3 H, T3′ + A3), 8.49 (d, J = 7.8 Hz, 2 H, T3),
8.42 (d, J = 8.1 Hz, 1 H, B3), 8.36 (d, J = 8.0 Hz, 1 H, T4′), 8.39–8.27
(m, 1 H, A4), 8.02 (dd, J = 8.0, 7.6 Hz, 2 H, T4), 8.06–7.92 (m, 1 H,
A5), 7.83 (dd, J = 7.8 Hz, 1 H, B4), 7.84–7.71 (m, 2 H, T6), 7.35 (dd,
J = 7.5, 5.5 Hz, 2 H, T5), 7.23 (d, J = 5.6 Hz, 1 H, B6), 7.08 (dd, J =
7.5, 5.6 Hz, 1 H, B5), 4.54 (dd, J = 8.0, 4.7 Hz, 1 H, H2), 4.34 (dd, J =
8.1, 4.3 Hz, 1 H, H3), 4.14 (dd, J = 9.2, 4.5 Hz, 1 H, M4), 3.59–3.54
(m, 2 H, H10), 3.51 (t, J = 5.0 Hz, 2 H, H13), 3.32 (t, J = 5.1 Hz, 2 H,
H9), 3.27 (t, J = 5.2 Hz, 2 H, H14), 3.24–3.15 (m, 1 H, H4), 2.88 (dd,
J = 13.0, 4.8 Hz, 1 H, H1a), 2.65 (d, J = 13.0 Hz, 1 H, H1b), 2.15 (t, J =
7.7 Hz, 3 H, H8), 2.01–1.98 (m, 1 H, M2), 1.88 (s, 3 H, M5), 1.85–1.45
(m, 5 H, M3 + H5 + H7), 1.35 (s, 3 H, M1), 1.31–1.22 (m, 1 H, H6).
ESI MS m/z (calc): 519.2 (519.2, [M – 2Cl]2+).
Characterization of [5]Cl4: Rf = 0.10 (SiO2, acetone/H2O/1 M HCl
[16:4:1]). 1H NMR (300 MHz, [D4]methanol): δ = (ppm): 9.86 (d, J =
5.4 Hz, 1 H, A6), 9.76 (d, J = 5.3 Hz, 1 H, A6*), 8.89–8.79 (m, 4 H, T3′),
8.81 (d, J = 8.3 Hz, 2 H, A3), 8.74–8.58 (m, 6 H, T3′′ + T3 + B3), 8.48–
8.36 (m, 4 H, A4 + T4′), 8.18–8.08 (m, 4 H, T4′′ + T4), 8.09–8.04 (m,
2 H, A5), 8.00–7.88 (m, 4 H, B4 + T6′′), 7.84–7.74 (m, 2 H, T6), 7.53–
7.42 (m, 4 H, T5′′ + T5), 7.32–7.20 (m, 4 H, B6 + B5), 4.28–4.21 (m,
1 H, M4), 4.21–4.12 (m, 2 H, H2 + H3), 3.58 (s, 4 H, H11 + H12), 3.52
(t, J = 5.9 Hz, 2 H, H10), 3.46 (t, J = 5.9 Hz, 2 H, H13), 3.40–3.31 (m,
2 H, H9), 3.30–3.23 (m, 2 H, H14), 2.33 (d, J = 11.7 Hz, 1 H, H4), 2.05
(t, J = 7.1 Hz, 2 H, H8), 1.95 (d, J = 12.2 Hz, 1 H, H1a), 1.89 (s, 3 H,
M5), 1.76 (dd, J = 12.2, 4.3 Hz, 1 H, H1b), 1.83–1.65 (m, 2 H, M2),
1.60 (dd, J = 10.5, 5.4 Hz, 2 H, M3), 1.50–1.35 (m, 1 H, H5b), 1.38 (s,
3 H, M1), 1.28–1.14 (m, 2 H, H7), 1.14–1.00 (m, 1 H, H6a), 0.66–0.53
(m, 1 H, H6b), 0.52–0.38 (m, 1 H, H5a). 13C NMR (75 MHz, [D4]metha-
nol): δ = (ppm): 175.7, 173.1 (d), 172.9, 159.6, 159.4, 158.7, 158.6,
158.5, 158.1, 158.1, 158.0, 154.8, 154.4, 154.3, 153.4 + 153.1 (A6),
150.8, 150.7, 140.4, 140.3, 139.8, 139.7, 139.6, 139.5, 138.6, 138.4,
129.9, 129.7, 129.2, 129.1, 128.6, 128.5, 126.7, 126.5, 126.4, 126.2,
126.0, 125.9, 125.6, 125.3, 125.2, 71.3 (C11 + 12), 70.5 (C10), 70.3
(C13), 60.2 (C3), 58.5 (C2), 57.5 (C4), 52.8 (M4), 40.5 (C1), 40.4 (C9),
40.2 (C14), 36.3 (C8), 31.3 (M3), 30.1 (M2), 28.0 (C6), 27.7 (C5), 26.3
(C7), 22.8 (M5), 14.2 (M1). ESI MS: m/z (calc): 528.1 (528.1, [M – 3Cl
+ H2O]3+), 405.1 (405.3, [M – 3Cl + Na + MeOH]4+). UV/Vis: λmax (ε
in L mol–1 cm–1) in pure H2O: 447 nm (1.16 × 104).
Optimization Attempts for the Synthesis of [Ru(tpy)(bpy)(1)]-
(PF6)2 {[6](PF6)2}: A solution of ligand 1 (52 mg, 0.095 mmol) in
H2O (2.9 mL) was added to acetone (0.9 mL). The solution was
deoxygenated with argon, after which [Ru(tpy)(bpy)(OH2)](PF6)2
(15 mg, 0.019 mmol) was added and the resulting solution was
heated [different conditions (see Table S1): 333 K, 353 K, or reflux]
under argon for either 2 or 48 h. The solvents were removed by
rotary evaporation at 303 K. The crude was purified by silica column
chromatography, using acetone/H2O/KPF6(sat) as the eluent, fol-
lowed by size exclusion chromatography (Sephadex LH-20) using
MeOH as the eluent in order to remove the excess KPF6 salt. Analy-
sis of the product composition in the different reaction conditions
was performed by 1H NMR (see Figure S1).
[Ru(tpy)(bpy)(2)](PF6)2 {[8](PF6)2}: Compound 2 (250 mg,
0.416 mmol) and [Ru(tpy)(bpy)(OH2)](PF6)2 (66.5 mg, 83.2 μmol)
were dissolved in degassed H2O (16 mL). The resulting solution was
stirred and heated to 353 K under argon for 47 h. The solvent was
removed by rotary evaporation at 303 K and the crude product
was purified by silica column chromatography, using acetone/H2O/
KPF6,sat. (12:4:1) as the eluent. Excess KPF6 was removed by size
exclusion chromatography (Sephadex LH-20) using MeOH as sol-
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vent. After evaporation of the solvent, an orange solid was ob-
tained. Yield: 94 mg (0.068 mmol, 82 %). Rf = 0.62 (SiO2, Acteon/
H2O/HCl [100:10:1]). 1H NMR (400 MHz, [D4]methanol): δ = (ppm):
9.84 (d, J = 5.1 Hz, 1 H, A6), 8.84 (d, J = 8.1 Hz, 1 H, A3), 8.79 (d, J =
8.3 Hz, 2 H, T5′), 8.77 (d, J = 8.4 Hz, 1 H, T3′), 8.66 (d, J = 8.0 Hz, 1
H, T3′′), 8.62 (d, J = 8.0 Hz, 1 H, T3), 8.60 (d, J = 8.1 Hz, 1 H, B3),
8.41 (ddd, J = 7.9, 7.9, 1.5 Hz, 1 H, A4), 8.40 (dd, J = 8.2, 8.2 Hz, 1
H, T4′), 8.12 (ddd, J = 7.8, 7.8, 1.5 Hz, 1 H, T4′′), 8.10 (ddd, J = 7.8,
7.8, 1.6 Hz, 1 H, T4), 8.08 (ddd, J = 7.7, 5.6, 1.3 Hz, 1 H, A5), 7.94
(ddd, J = 8.2, 7.4, 1.6 Hz, 1 H, B4), 7.91 (dd, J = 5.5, 0.6 Hz, 1 H,
T6′′), 7.78 (dd, J = 5.5, 0.8 Hz, 1 H, T6), 7.47 (ddd, J = 7.7, 5.5, 1.2 Hz,
1 H, T5′′), 7.44 (ddd, J = 7.6, 5.6, 1.3 Hz, 1 H, T5), 7.29–7.22 (m, 2 H,
B6 + B5), 4.49 (dd, J = 7.8, 4.5 Hz, 1 H, H2), 4.31 (dd, J = 7.9, 4.4 Hz,
1 H, H3), 4.20 (dd, J = 8.4, 4.5 Hz, 1 H, H2′), 4.16 (dd, J = 8.4, 4.4 Hz,
1 H, H3′), 3.63 (s, 4 H, H11 + H11′), 3.60–3.51 (m, 4 H, H10 + H10′),
3.41–3.32 (m, 4 H, H9 + H9′), 3.21 (ddd, J = 8.8, 5.9, 4.4 Hz, 1 H, H4),
2.92 (dd, J = 12.8, 4.9 Hz, 1 H, H1b), 2.69 (d, J = 12.7 Hz, 1 H, H1A),
2.32 (ddd, J = 11.6, 4.4, 2.5 Hz, 1 H, H4′), 2.21 (t, J = 7.4 Hz, 2 H,
H8), 2.06 (t, J = 7.1 Hz, 2 H, H8′), 1.93 (d, J = 12.2 Hz, 1 H, H1′a),
1.75 (dd, J = 12.2, 4.6 Hz, 1 H, H1′b), 1.72–1.51 (m, 4 H, H7 + H5),
1.51–1.36 (m, 3 H, H5′b + H6), 1.31–1.20 (m, 2 H, H7′), 1.15–1.02 (m,
1 H, H6′b), 0.65–0.53 (m, 1 H, H6′a), 0.53–0.43 (m, 1 H, H5′a). 13C
NMR (101 MHz, [D4]methanol): δ = (ppm): 176.1 (b), 175.7 (b′), 165.2
(a′), 159.5, 159.3, 158.4, 158.1, 154.7 (T6′′), 154.3 (T6), 153.1 (A6),
150.6 (B6), 140.4 (T4 + T4′′), 139.8 (A4), 139.6 (B4), 138.7 (T4′), 129.8
(T5), 129.7 (T5′′), 129.1 (A5), 128.6 (B5), 126.6 (T3′′), 126.4 (B3), 126.2
(A3), 126.0 (T3′), 125.8 (T3′), 125.2 (T3), 71.2 (C11 + C11′), 70.5 (C10
+ C10′), 63.3 (C3), 61.6 (C2), 60.2 (C3′), 58.5 (C2′), 57.4 (C4′), 57.0
(C4), 41.1 (C1), 40.5 (C1′), 40.3 (C9 + C9′), 36.8 (C8), 36.3 (C8′), 29.7
(C6), 29.5 (C5), 28.0 (C6′), 27.8 (C5′), 26.9 (C7), 26.3 (C7′). ESI MS: m/z
(calc): 545.4 (545.7, [M]2+). Elemental analysis calcd. (%) for
C51H63F12N11O6P2RuS2 + 1 H2O: C 43.78, H 4.68, N 11.01; found C
43.81, H 4.54, N 11.04. UV/Vis: λmax (ε in L mol–1 cm–1) in pure H2O:
448 nm (5.50 × 103).
Photochemistry
Determination of Extinction Coefficients: A stock solution of
[8](PF6)2 (4.2 mg in 10.0 mL of H2O, 3.0 × 10–4 M) was prepared.
Concentration series of 5 different concentrations were prepared by
adding x mL of the stock solution (x = 0.40, 0.60, 0.80, 1.00, and
1.20 mL) to a quartz cuvette filled with 3.00-x mL H2O or PBS buffer.
Absorbance spectra were measured for each sample, and the ex-
tinction coefficient of both complexes was determined from the
slope of a plot of the absorbance vs. concentration at each wave-
length.
Kinetics of Photosubstitution of [8](PF6)2: A stock solution of
[8](PF6)2 (0.6 mg in 2.5 mL of PBS solution, 1.7 × 10–4 M) was pre-
pared. To investigate the photochemical properties of complex
[8](PF6)2 x mL of stock solution (x = 1.30 mL) was added to a quartz
cuvette filled with 3.00–x mL PBS solution. Final concentration of
[8]2+ was 7.5 × 10–5 M. The sample was deoxygenated with argon
for 20 min. Irradiation was performed using a custom 465 nm LED
(Δλ1/2 = 25 nm, 1.4 mW, 220 min, 19 J × cm–2), and the samples
were stirred under argon and kept at 297 K for the duration of
the experiment. During irradiation UV/Vis absorbance spectra were
measured at variable time intervals, ranging from every 0.5 to
10 min. Mass spectrometry was used to determine the products
presence in the solution after irradiation. Irradiation of 6.0 10–5 M
[8](PF6)2 in absence and presence of one equivalent of streptavidin
was performed in NaH2PO4 buffer (3.00 mL, 20 mM, pH 7.0) at 298 K.
After deoxygenation with nitrogen irradiation occurred at 298 K
under nitrogen flow with the above-mentioned 465 nm LED at
3.30 W = 4.46 × 10–8 mol s–1.
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HABA Displacement Titration: For each experiment streptavidin
was added to a HABA solution (1.07 mM) in NaH2PO4 buffer (2.7 mL,
20 mM, pH 7.0) in a cuvette resulting in concentration of tetrameric
streptavidin of 6.26 μM for the measurement with biotin and
7.27 μM with [8](PF6)2. The solution equilibrated for five minutes.
UV/Vis spectra of this sample were recorded using the buffer as
background. Aliquots (5 μL) of biotin in buffer (1.56 mM) or [8](PF6)2
in methanol (1.26 mM) were added and after each addition, a spec-
trum was recorded.
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